(Reuters) -Shares of Metsera fell over 15% in premarket trading on Monday, after the weight-loss drug developer accepted a ...
Pharmaceutical giant Pfizer has finally acquired development-stage obesity drugmaker Metsera Inc., in an intense bidding war against the Danish drugmaker Novo Nordisk for over $10 billion.
The new Moderna COVID vaccine, mNexspike, is approved for adults 65 and older and people 12 to 64 with an underlying medical ...
Pfizer has axed 11 programs, including two pipeline assets from its $43 billion Seagen acquisition, work on a ...
LINCOLN — Pharmaceutical giant Pfizer again has demanded that the State of Nebraska return any lethal injection drugs manufactured by the company but made it clear that it will not go to court to ...